<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03160573</url>
  </required_header>
  <id_info>
    <org_study_id>UHRG-RPR-Malodor-ADA-2016</org_study_id>
    <nct_id>NCT03160573</nct_id>
  </id_info>
  <brief_title>Controlling Oral Malodor by ClōSYS Oral Rinse</brief_title>
  <official_title>Efficacy of ClōSYS Oral Rinse Products in Human Subjects in Controlling Oral Malodor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rowpar Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Health Resources Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rowpar Pharmaceuticals, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this Study is to assess the efficacy of two ClōSYS Oral Rinse products in&#xD;
      human subjects in controlling oral malodor in partial fulfillment of the requirements for&#xD;
      recognition by the American Dental Association's (ADA) requirement for obtaining ADA Seal for&#xD;
      malodor.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Design:&#xD;
&#xD;
      The products used in this study are: ClōSYS Alcohol-Free Oral Rinse (referred here as ClōSYS&#xD;
      Unflavored Oral Rinse) and ClōSYS justRIGHT MILD MINT Oral Rinse (referred here as ClōSYS&#xD;
      Flavored Oral Rinse). This is an in-vivo, eight-week, a single-center, randomized,&#xD;
      double-blind (subject/investigator), 2-waycross-overdesign clinical study. There will be two&#xD;
      independent groups. Each subject of each group will be crossed over to the other group within&#xD;
      a same group after the washout period. Each group will have their own control group. In the&#xD;
      first phase, 25 subjects (50%) of each group will randomly be assigned to the active group;&#xD;
      the other 25 subjects will be assigned to the control group. In the second phase, the&#xD;
      participants will be crossed over of group assignment. The Study will enroll 100 subjects,&#xD;
      aged 21 to 65 years, with a slight to strong intrinsic oral malodor, as determined by a panel&#xD;
      of trained odor judges calibrated and standardized using a range of standard odorants&#xD;
      sufficient to reflect the different patterns of nose receptors.&#xD;
&#xD;
      Study Plan:&#xD;
&#xD;
      Subjects will receive verbal and written oral hygiene instructions, and either one bottle (16&#xD;
      oz. each) of ClōSYS Unflavored Oral Rinse, ClōSYS Flavored Oral Rinse- or Placebo Oral Rinse&#xD;
      each week. Subjects will also receive measuring cups for dispensing the rinse and a diary log&#xD;
      for recording usage (the Oral Hygiene Kit) for use during the treatment. After a 2-week wash&#xD;
      out period, each subject will receive another bottle of oral rinse according to their group&#xD;
      assignment. The rinse bottles will be weighed prior to dispensing the product. A product log&#xD;
      will be maintained and the weights of the bottles will be documented at each visit.&#xD;
&#xD;
      Subjects will be instructed to rinse twice a day, each in the morning and in the evening,&#xD;
      with 15 mL mouth rinse for 30 seconds. They will note in their patient's log the date and&#xD;
      time of rinsing.&#xD;
&#xD;
      Subjects will be instructed to continue with their normal oral hygiene practices, including&#xD;
      tooth brushing and flossing but omitting any use of oral rinses or mouthwashes except for the&#xD;
      Study materials. The subjects also will be instructed not to use other non-study related&#xD;
      products such as breath mints, lozenge, gums, etc. as well as refraining from elective dental&#xD;
      procedures during the study period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in Malodor as Measured by Organoleptic Score</measure>
    <time_frame>Weekly for three weeks</time_frame>
    <description>A 6-level organoleptic score from 0 - 5 will be used. Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">99</enrollment>
  <condition>Oral Malodor</condition>
  <arm_group>
    <arm_group_label>Test-Unflavored Rinse then Placebo Unflavored Rinse</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution for 3 weeks,. After a washout period of 2 weeks, they will then receive Placebo unflavored rinse containing containing NO 0.1% stabilized chlorine dioxide for 3 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test-Flavored Rinse then Placebo Flavored Rinse</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution for 3 weeks. After a washout period of 2 weeks, they will then receive Placebo flavored rinse containing NO 0.1% stabilized chlorine dioxide for 3 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flavored Oral Rinse-Placebo then Test-Flavored Rinse</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive CloSYS mint flavored rinse containing NO 0.1% stabilized chlorine dioxide for 3 weeks. After a washout period of 2 weeks, they will then receive CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution for 3 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unflavored Oral Rinse-Placebo then Test-Unflavored Rinse</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive CloSYS unflavored rinse containing NO 0.1% stabilized chlorine dioxide for 3 weeks. After a washout period of 2 weeks, they will then receive unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution for 3 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ClōSYS® Unflavored Rinse</intervention_name>
    <arm_group_label>Test-Unflavored Rinse then Placebo Unflavored Rinse</arm_group_label>
    <other_name>Mouth rinse</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ClōSYS® Flavored Rinse</intervention_name>
    <arm_group_label>Test-Flavored Rinse then Placebo Flavored Rinse</arm_group_label>
    <other_name>Mouth rinse</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo-Flavored Oral Rinse</intervention_name>
    <description>Flavor-matched placebo rinse</description>
    <arm_group_label>Flavored Oral Rinse-Placebo then Test-Flavored Rinse</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo-Unflavored Oral Rinse</intervention_name>
    <description>Unflavored-matched placebo rinse</description>
    <arm_group_label>Unflavored Oral Rinse-Placebo then Test-Unflavored Rinse</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject has read, signed, and received a copy of the Informed Consent prior to Study&#xD;
             initiation.&#xD;
&#xD;
          2. Subject is able to follow verbal and/or written instructions, perform oral hygiene&#xD;
             procedures and return to the test facility for specified Study examinations.&#xD;
&#xD;
          3. Subject is between the ages of 21 and 65 years of age, male or female.&#xD;
&#xD;
          4. Subject has normal oral interior cheek wall tissues.&#xD;
&#xD;
          5. Subject is in good general health as determined by medical history and clinical&#xD;
             judgment that no severe or debilitating disease exists that would impede participation&#xD;
             in the Study.&#xD;
&#xD;
          6. Subject must have an average organoleptic intensity rating of at least 2.6 but maximum&#xD;
             4.5 on an intensity scale of 0-5.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or nursing per subject report.&#xD;
&#xD;
          2. Diagnosis of Xerostomia, including medication induced Xerostomia.&#xD;
&#xD;
          3. Any oral or extraoral piercing that interferes with the ability to perform study&#xD;
             procedures and/or clinical assessments in the mouth.&#xD;
&#xD;
          4. Fixed or removable oral appliance, such as orthodontic brackets or retainer, partial&#xD;
             or complete dentures.&#xD;
&#xD;
          5. Have advanced periodontal disease or excessive gingival recession, per&#xD;
             Investigator/Examiner discretion.&#xD;
&#xD;
          6. A known allergy or sensitivity to products planned for use in this study.&#xD;
&#xD;
          7. Unwillingness to abstain from all other oral hygiene products other than those&#xD;
             prescribed for the duration of the study.&#xD;
&#xD;
          8. Heavy deposits of calculus, either supragingival and/or subgingival, per&#xD;
             Investigator/Examiner discretion.&#xD;
&#xD;
          9. Have a history of severe transmittable infectious disease (hepatitis, HIV,&#xD;
             tuberculosis).&#xD;
&#xD;
         10. Have a medical or dental condition that would be unduly affected by participation in&#xD;
             this study, per Investigator discretion.&#xD;
&#xD;
         11. Any other condition that Principal Investigator would consider interfering with the&#xD;
             study.&#xD;
&#xD;
         12. Smokers.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sushma Nachnani, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Resources Group, Inc.</affiliation>
  </overall_official>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <results_first_submitted>September 7, 2020</results_first_submitted>
  <results_first_submitted_qc>November 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 22, 2020</results_first_posted>
  <last_update_submitted>November 28, 2020</last_update_submitted>
  <last_update_submitted_qc>November 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03160573/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>United Health Resources Group (UHRG) was responsible for recruitment using advertising and volunteers from their website. All patients were recruited at a single UHRG site (7721 S. Painter Ave, Whittier, CA 90602)</recruitment_details>
      <pre_assignment_details>No significant events prior to assignment to an arm.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Test-Unflavored Rinse Then Placebo-Unflavored Rinse</title>
          <description>CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Unflavored Rinse: Subjects in Test group will receive ClōSYS® Unflavored Rinse then Placebo-Unflavored rinse</description>
        </group>
        <group group_id="P2">
          <title>Test-Flavored Rinse Then Placebo-Flavored Rinse</title>
          <description>CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Flavored Rinse: Subjects in Test group will receive ClōSYS® Flavored Rinse then Placebo Flavored Rinse</description>
        </group>
        <group group_id="P3">
          <title>Flavored Oral Rinse-Placebo Then Test-Flavored Rinse</title>
          <description>CloSYS mint flavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Flavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Flavored Rinse then CloSYS mint flavored rinse containing 0.1% stabilized chlorine dioxide</description>
        </group>
        <group group_id="P4">
          <title>Unflavored Oral Rinse-Placebo Then Test-Unflavored Oral Rinse</title>
          <description>CloSYS unflavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Unflavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Unflavored Rinse then CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Sequence (3 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Washout (2 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Sequence (3 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="23"/>
                <participants group_id="P3" count="23"/>
                <participants group_id="P4" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Test-Unflavored Rinse Then Placebo Unflavored Rinse</title>
          <description>CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Unflavored Rinse: Subjects in Test group will receive ClōSYS® Unflavored Rinse then CloSYS unflavored rinse containing NO 0.1% stabilized chlorine dioxide.</description>
        </group>
        <group group_id="B2">
          <title>Test-Flavored Rinse Then Placebo Flavored Rinse</title>
          <description>CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Flavored Rinse: Subjects in Test group will receive ClōSYS® Flavored Rinse then CloSYS mint flavored rinse containing NO 0.1% stabilized chlorine dioxide.</description>
        </group>
        <group group_id="B3">
          <title>Flavored Oral Rinse-Placebo Then Test-Flavored Rinse</title>
          <description>CloSYS mint flavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Flavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Flavored Rinse then CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution.</description>
        </group>
        <group group_id="B4">
          <title>Unflavored Oral Rinse-Placebo Then Unflavored Oral Rinse</title>
          <description>CloSYS unflavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Unflavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Unflavored Rinse then CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="99"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="99"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="66"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="11"/>
                    <measurement group_id="B5" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="68"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="86"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Reduction in Malodor as Measured by Organoleptic Score</title>
        <description>A 6-level organoleptic score from 0 - 5 will be used. Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor.</description>
        <time_frame>Weekly for three weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Test-Unflavored Rinse Then Placebo Unflavored Rinse</title>
            <description>CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Unflavored Rinse: Subjects in Test group will receive ClōSYS® Unflavored Rinse then Placebo Unflavored rinse</description>
          </group>
          <group group_id="O2">
            <title>Test-Flavored Rinse Then Placebo Flavored Rinse</title>
            <description>CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Flavored Rinse: Subjects in Test group will receive ClōSYS® Flavored Rinse then Placebo Flavored Rinse</description>
          </group>
          <group group_id="O3">
            <title>Flavored Oral Rinse-Placebo Then Test Flavored Oral Rinse</title>
            <description>CloSYS mint flavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Flavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Flavored Rinse then Test Flavored Oral Rinse</description>
          </group>
          <group group_id="O4">
            <title>Unflavored Oral Rinse-Placebo Then Test Unflavored Oral Rinse</title>
            <description>CloSYS unflavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Unflavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Unflavored Rinse</description>
          </group>
        </group_list>
        <measure>
          <title>Reduction in Malodor as Measured by Organoleptic Score</title>
          <description>A 6-level organoleptic score from 0 - 5 will be used. Score of 0 indicating malodor cannot be detected and score of 5 indicating very strong malodor.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="23"/>
                <count group_id="O4" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.58" spread="0.67"/>
                    <measurement group_id="O2" value="3.60" spread="0.63"/>
                    <measurement group_id="O3" value="3.63" spread="0.62"/>
                    <measurement group_id="O4" value="3.65" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.93" spread="0.40"/>
                    <measurement group_id="O2" value="2.19" spread="0.51"/>
                    <measurement group_id="O3" value="3.03" spread="0.64"/>
                    <measurement group_id="O4" value="2.29" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.39" spread="0.61"/>
                    <measurement group_id="O2" value="1.45" spread="0.51"/>
                    <measurement group_id="O3" value="2.73" spread="0.60"/>
                    <measurement group_id="O4" value="1.81" spread=".58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.30" spread=".67"/>
                    <measurement group_id="O2" value="1.15" spread="0.37"/>
                    <measurement group_id="O3" value="2.65" spread="0.56"/>
                    <measurement group_id="O4" value="1.40" spread=".61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.28" spread="0.52"/>
                    <measurement group_id="O2" value="3.25" spread="0.52"/>
                    <measurement group_id="O3" value="3.05" spread="0.38"/>
                    <measurement group_id="O4" value="3.21" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 1-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" spread="0.35"/>
                    <measurement group_id="O2" value="2.08" spread="0.56"/>
                    <measurement group_id="O3" value="2.89" spread="0.47"/>
                    <measurement group_id="O4" value="2.08" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.91" spread="0.35"/>
                    <measurement group_id="O2" value="1.48" spread="0.60"/>
                    <measurement group_id="O3" value="2.83" spread="0.50"/>
                    <measurement group_id="O4" value="1.47" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3-2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.90" spread="0.35"/>
                    <measurement group_id="O2" value="1.25" spread="0.47"/>
                    <measurement group_id="O3" value="2.83" spread="0.50"/>
                    <measurement group_id="O4" value="1.34" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Test Flavored Rinse, Placebo Flavored Rinse</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.00001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Test Unflavored Rinse, Placebo Unflavored Rinse</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.00001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks for each intervention, 2 weeks for washout</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Test-Unflavored Rinse</title>
          <description>CloSYS unflavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Unflavored Rinse: Subjects in Test group will receive ClōSYS® Unflavored Rinse</description>
        </group>
        <group group_id="E2">
          <title>Test-Flavored Rinse</title>
          <description>CloSYS mint-flavored rinse containing 0.1% stabilized chlorine dioxide (sodium chlorite) in an aqueous solution&#xD;
ClōSYS® Flavored Rinse: Subjects in Test group will receive ClōSYS® Flavored Rinse</description>
        </group>
        <group group_id="E3">
          <title>Flavored Oral Rinse-Placebo</title>
          <description>CloSYS mint flavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Flavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Flavored Rinse</description>
        </group>
        <group group_id="E4">
          <title>Unflavored Oral Rinse-Placebo</title>
          <description>CloSYS unflavored rinse containing NO 0.1% stabilized chlorine dioxide&#xD;
Unflavored Oral Rinse - Placebo: Subjects in Placebo group will receive Placebo Unflavored Rinse</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sushma Nachnani, MS, PhD</name_or_title>
      <organization>University Health Resources Group</organization>
      <phone>(310) 645-8576</phone>
      <email>sushnach@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

